Vinflunine Ditartrate

酒石酸长春氟宁

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameVinflunine Ditartrate
Drug Alias Name长春瑞宾双酒石酸盐vinflunina长春氟宁vinfluninumJavlor +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[15] 
Global Approved IndicationsUrologic NeoplasmsCarcinoma, Transitional Cell
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/09/21
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPierre Fabre Médicament ProductionPierre Fabre Medicament
Inactive CompaniesBristol Myers Squibb SrlcompanyNational Cancer InstituteThe Institute Of Cancer Research, London +[4] 
Active IndicationsUrologic NeoplasmsBreast NeoplasmsCarcinoma, Transitional Cell
Inactive IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[12] 

Other Information

ATC CodeL01CA05
Related LinksWikipediaDrugBankKEGG